Nurocor Acquires Industry-Leading Metadata Repository

Austin, TX, November 15, 2017 (Newswire.com) - Nurocor announced today that it has acquired Semantics Manager, the industry-leading clinical standards metadata repository from Akana, a Rogue Wave company. With more than 115 man years of engineering behind it, this technology provides a truly enterprise-class solution for the standards and metadata management challenges facing the BioPharma industry.

Nurocor's mission is to bring order to clinical data. The world of clinical data is becoming increasingly complex and Nurocor believes that through disciplined management of data standards and semantics, BioPharma companies can control this complexity and turn it into a business advantage.

"CDISC is pleased to continue our partnership with the Nurocor team to bring additional value to our stakeholders and members, Nurocor MDR helps us manage the publication and distribution of our standards through CDISC SHARE."

David R. Bobbitt, CDISC President and CEO

Founded by industry professionals with a deep understanding of the technical aspects of a metadata repository (MDR), Nurocor is completely focused on addressing the standards and metadata challenges facing the BioPharma industry throughout the R&D data lifecycle.

Nurocor has worked closely with CDISC to help CDISC achieve its mission to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. The Semantics Manager product, now called Nurocor MDR, provides the core platform for CDISC SHARE. Nurocor remains committed to working with CDISC to improve the quality of medical research by advancing the adoption of clinical metadata standards throughout the industry.

"CDISC is pleased to continue our partnership with the Nurocor team to bring additional value to our stakeholders and members," said David R. Bobbitt, CDISC President and CEO. "Nurocor MDR helps us manage the publication and distribution of our standards through CDISC SHARE."

Nurocor works with many of the world's largest companies including Amgen, inventive Health, Novartis, Pfizer, and Roche, helping them bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly.

Founded by a team combining deep industry expertise with a proven ability to bring technology solutions to market, and backed by established venture capital and private equity funds, Nurocor is uniquely positioned to address the standards and metadata challenges facing the BioPharma industry. The Nurocor team has extensive knowledge of the BioPharma business, the R&D data lifecycle, and expertise in the practical application of standards development and implementation. It also has an extensive track record of successfully delivering technology solutions to the enterprise.

About Nurocor

Nurocor helps companies like Amgen, inventive Health, Novartis, Pfizer, and Roche bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly. Created by a team combining deep industry expertise with a proven ability to bring technology solutions to market, Nurocor MDR is the industry-leading standards metadata repository enabling the seamless interchange of data between Electronic Data Capture and Clinical Data Management systems and regulatory agencies.

Source: Nurocor